Corporate venture capital often faces a credibility challenge – positioned between strategic objectives and financial performance, many CVCs struggle to deliver lasting value for either startups or their corporate parents. BMW i Ventures takes a different approach: operating with the discipline of an institutional venture fund while benefiting from deep integration with one of the world’s most advanced industrial ecosystems.
This episode of 0100 Impact Talks was recorded at SLUSH in Helsinki, where Inga G. Grieger, Managing Director at BMW i Ventures, shared insights into how this model works in practice — and what it takes for corporate-backed venture capital to succeed beyond strategic intent.
As private equity adapts to a prolonged high-cost environment, investors are being forced to rethink how they source deals, create value, and deploy capital. Ahead of her appearance at 0100 Europe (April 21–23), we spoke with Geraldine O’Keeffe, Partner at EQT Healthcare Growth, about how one of Europe’s leading investment platforms is transiting today’s market dynamics—across healthcare, technology, and beyond.
